Wednesday, July 8, 2026

Drug profile · INN

paroxetine hydrochloride

paroxetine hydrochloride (PAROXETINE HYDROCHLORIDE) is a serotonin transporter inhibitor. Associated with Teva Pharma GmbH. Route of administration: oral. Current US regulatory status: approved.

FDA: approved
US status approved
Patents linked 5
Pipeline programs 3
News articles 0
Drug details — paroxetine hydrochloride
US status
approved
Class
Route
ORAL
Patents
5
Programs
3
Data quality
0.89

Quick answer

paroxetine hydrochloride (PAROXETINE HYDROCHLORIDE) is a serotonin transporter inhibitor. Associated with Teva Pharma GmbH. Route of administration: oral. Current US regulatory status: approved.

Key facts

INN paroxetine hydrochloride
Brand PAROXETINE HYDROCHLORIDE
Mechanism Serotonin transporter inhibitor
Target Sodium-dependent serotonin transporter
Route ORAL
Formulation TABLET, EXTENDED RELEASE

Mechanism of action

Serotonin transporter inhibitor

Primary target: Sodium-dependent serotonin transporter

Approval history

Authority Status Date
FDA approved

Pipeline programs

  1. INTENSIFY MDD Phase 3 · Disc Medicine · Major depressive disorder
  2. Paroxetine HCl Phase 1 · Teva Pharma · Healthy
  3. Paroxetine Unknown · BRIGHT MINDS BIOSCIENCES · Tobacco Use Disorder

Related & competitor drugs

  1. citalopram hydrobromide Serotonin transporter inhibitor
  2. clomipramine hydrochloride Serotonin transporter inhibitor
  3. escitalopram oxalate Serotonin transporter inhibitor
  4. fluoxetine hydrochloride Serotonin transporter inhibitor
  5. fluvoxamine maleate Serotonin transporter inhibitor
  6. sertraline hydrochloride Serotonin transporter inhibitor
  1. US 8987294

    Small molecule inhibitors of the α4-paxillin interaction

    Expires Mon Mar 19 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  2. US 7396542

    Stable pharmaceutical formulation of paroxetine hydrochloride anhydrous and a process for preparation thereof

    Expires Mon Jul 03 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  3. US 7357945

    Stable pharmaceutical formulation of paroxetine hydrochloride and a process for preparation thereof

    Expires Mon Apr 10 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  4. US 7138137

    Stable pharmaceutical formulation of paroxetine hydrochloride and a process for preparation thereof

    Expires Mon Nov 16 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  5. US 6930186

    Process for the preparation of paroxetine substantially free of alkoxy impurities

    Expires Mon Aug 11 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

Frequently asked questions

What is paroxetine hydrochloride?

paroxetine hydrochloride (PAROXETINE HYDROCHLORIDE) is a serotonin transporter inhibitor. Associated with Teva Pharma GmbH. Route of administration: oral. Current US regulatory status: approved.

What is the brand name for paroxetine hydrochloride?

PAROXETINE HYDROCHLORIDE is a marketed brand name for paroxetine hydrochloride. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of paroxetine hydrochloride?

paroxetine hydrochloride has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.